Literature DB >> 28331996

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.

Carlo Fremd1, Carolin C Hack2, Andreas Schneeweiss1, Geraldine Rauch3, Diethelm Wallwiener4, Sara Yvonne Brucker4, Florin-Andrei Taran4, Andreas Hartkopf4, Friedrich Overkamp5, Hans Tesch6, Tanja Fehm7, Peyman Hadji8, Wolfgang Janni9, Diana Lüftner10, Michael P Lux2, Volkmar Müller11, Johannes Ettl12, Erik Belleville13, Christof Sohn14, Florian Schuetz14, Matthias M Beckmann2, Peter A Fasching2, Markus Wallwiener15.   

Abstract

PURPOSE: The present study aims to analyze a cohort of advanced breast cancer patients in Germany to assess their interest in complementary and alternative medicine (CAM) and patient's use of most frequent CAM methods. PATIENTS AND METHODS: Based on the PREGNANT real-time breast cancer registry which is a multicenter study in Germany, questionnaires of 580 patients with advanced breast cancer were evaluated. The implemented questionnaire for CAM asked for general interest in CAM and for patient's use of different CAM methods at present and in the past. The interest and application of CAM were analyzed for association with patients' characteristics such as tumor, patient, and therapy characteristics.
RESULTS: In total, 436 out of 580 (75%) patients claimed to be interested in CAM. Further, interest in CAM is significantly correlated with younger age and absence of metastasis at the time of diagnosis. Multivariate analysis confirmed the patient's age and distant disease status at the time of diagnosis as related to interest in CAM. A total of 56.4% of patients applied any CAM method in the past. Moreover, with increasing lines of therapies, the more frequent use of CAM was observed. Hereby, praying, vitamin supplements, and other food supplements were most frequently applied.
CONCLUSION: Our data demonstrate high overall interest and frequent use of CAM in advanced breast cancer patients supporting a strong demand of breast cancer patients for complementary counseling and treatments additional to the established cancer therapies. It is indispensable to implement counseling and evidence-based complementary treatments into clinical routine of cancer centers and to adapt postgraduate medical education, respectively.

Entities:  

Keywords:  Alternative medicine; Breast cancer; Complementary medicine; Integrative medicine; Oncology

Mesh:

Year:  2017        PMID: 28331996     DOI: 10.1007/s00404-017-4348-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

1.  Complementary and alternative medicine use in patients before and after a cancer diagnosis.

Authors:  C A Buckner; R M Lafrenie; J A Dénommée; J M Caswell; D A Want
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients.

Authors:  Nikolas Schuerger; Evelyn Klein; Alexander Hapfelmeier; Marion Kiechle; Christine Brambs; Daniela Paepke
Journal:  Breast Care (Basel)       Date:  2018-10-23       Impact factor: 2.860

3.  Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes.

Authors:  Maja Tank; Kristina Franz; Emanuele Cereda; Kristina Norman
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-06       Impact factor: 4.553

4.  Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey.

Authors:  Evelyn Klein; Matthias W Beckmann; Werner Bader; Cosima Brucker; Gustav Dobos; Dorothea Fischer; Volker Hanf; Annette Hasenburg; Sebastian M Jud; Matthias Kalder; Marion Kiechle; Sherko Kümmel; Andreas Müller; Myrjam-Alice T Müller; Daniela Paepke; Andre-Robert Rotmann; Florian Schütz; Anton Scharl; Petra Voiss; Markus Wallwiener; Claudia Witt; Carolin C Hack
Journal:  Arch Gynecol Obstet       Date:  2017-06-08       Impact factor: 2.344

5.  Greater Well-Being in More Physically Active Cancer Patients Who Are Enrolled in Supportive Care Services.

Authors:  Maíra Tristão Parra; Naghmeh Esmeaeli; Jordan Kohn; Brook L Henry; Stephen Klagholz; Shamini Jain; Christopher Pruitt; Daniel Vicario; Wayne Jonas; Paul J Mills
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

6.  Supportive Infusions in Integrative Breast and Gynecological Oncology - Report on Patients' Satisfaction and Self-reported Effects and Side Effects.

Authors:  Carolin C Hack; Sophia Antoniadis; Matthias W Beckmann; Anna Lisa Brandl; Peter A Fasching; Janina Hackl; Hanna Langemann; Stock Katja; Natalie Weber; Anna-Katharin Theuser
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-11-26       Impact factor: 2.915

7.  Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology.

Authors:  Loisa Drozdoff; Evelyn Klein; Matthias Kalder; Christine Brambs; Marion Kiechle; Daniela Paepke
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

8.  Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients.

Authors:  Daniela Paepke; Clea Wiedeck; Alexander Hapfelmeier; Kristina Karmazin; Marion Kiechle; Christine Brambs
Journal:  Breast Care (Basel)       Date:  2019-10-29       Impact factor: 2.860

9.  Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients.

Authors:  C C Hack; L Häberle; S Y Brucker; W Janni; B Volz; C R Loehberg; A D Hartkopf; C-B Walter; G Baake; A Fridman; W Malter; R Wuerstlein; N Harbeck; O Hoffmann; S Kuemmel; B Martin; C Thomssen; H Graf; C Wolf; M P Lux; C M Bayer; C Rauh; K Almstedt; P Gass; F Heindl; T Brodkorb; L Willer; C Lindner; H-C Kolberg; P Krabisch; M Weigel; D Steinfeld-Birg; A Kohls; C Brucker; V Schulz; G Fischer; V Pelzer; B Rack; M W Beckmann; T Fehm; A Rody; N Maass; A Hein; P A Fasching; N Nabieva
Journal:  Breast       Date:  2020-01-08       Impact factor: 4.380

10.  Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.

Authors:  Loisa Drozdoff; Evelyn Klein; Marion Kiechle; Daniela Paepke
Journal:  BMC Complement Altern Med       Date:  2018-09-24       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.